2023 annual financial data
Neuropace 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -30.11%.
Operating income was -27,174,000 USD and net income was -32,956,000 USD.
Operating cash flow was -19,701,000 USD.
Get free Neuropace email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 65,421,000 USD
- Operating income
- -27,174,000 USD
- Net income
- -32,956,000 USD
- Operating cash flow
- -19,701,000 USD